Menu

New tumor cases show common gene therapy tool can come with risk
📰

New tumor cases show common gene therapy tool can come with risk

Business - Latest - Google News·9 days ago
#aTRFz5Hy
#world#news#statnews#stat#viruses
Reading 0:00
15s threshold

For two decades, researchers debated whether adeno-associated viruses, the small viruses used to deliver new genes into thousands of patients, could in certain cases drive tumors. That debate is over.

A series of cases this year has presented powerful evidence that adeno-associated viruses, or AAVs, can cause cancer, forcing researchers and families to weigh the newly confirmed risk against the technology’s lifesaving potential — and hopefully determine how to design better therapies in the future.

“It will change the calculus for some patients,” said Sam Mackenzie, a neurologist at University of Rochester, speaking specifically about spinal muscular atrophy patients. 

STAT+ Exclusive Story

Already have an account? Log in

STAT+

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe